82
Participants
Start Date
June 30, 2013
Primary Completion Date
August 31, 2016
Study Completion Date
March 31, 2017
ALD-301
Ten 1ml injections of ALD-301 in the index calf and posterior, lower thigh
Placebo (vehicle)
Ten 1ml injections of placebo in the index calf and posterior, lower thigh
University of Florida-Department of Medicine, Gainesville
Orlando Health Inc., Orlando
University of Miami-Interdisciplinary Stem Cell Institute, Miami
University of Louisville, Louisville
Indiana Center for Vascular Biology and Medicine, Indianapolis
Minneapolis Heart Institute Foundation, Minneapolis
Clinical and Translational Science Institute at University of Minnesota, Minneapolis
Texas Heart Institute, Houston
Stanford University School of Medicine (Falk Cardiovascular Research Center), Stanford
Collaborators (1)
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Aldagen
INDUSTRY
Center for Cell and Gene Therapy, Baylor College of Medicine
OTHER
The University of Texas Health Science Center, Houston
OTHER